US5648084A
(en)
*
|
1990-02-28 |
1997-07-15 |
Guttag; Alvin |
Multiple dosage medicine drop bottle
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
US5684169A
(en)
*
|
1992-11-27 |
1997-11-04 |
Ensuiko Sugar Refining Co., Ltd. |
Cyclodextrin inclusion complex of taxol, and method for its production and its use
|
US5494901A
(en)
*
|
1993-01-05 |
1996-02-27 |
Javitt; Jonathan C. |
Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
|
ATE177635T1
(de)
*
|
1993-04-22 |
1999-04-15 |
Senju Pharma Co |
Wässrige arzneizubereitungen enthaltend argatroban und cyclodextrin oder coffein
|
WO1995005199A1
(en)
*
|
1993-08-19 |
1995-02-23 |
Dextran Products Limited |
Pharmaceutical preparation and a process for making same
|
SI9300470A
(en)
*
|
1993-09-10 |
1995-04-30 |
Lek Tovarna Farmacevtskih |
Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
|
KR100374924B1
(ko)
*
|
1994-04-22 |
2003-07-22 |
퀸스 유니버시티 엣 킹스톤 |
남성발기기능장애를회복시키고진단하기위한설하용량형
|
US6395744B1
(en)
|
1994-04-22 |
2002-05-28 |
Queen's University At Kingston |
Method and compositions for the treatment or amelioration of female sexual dysfunction
|
US6121276A
(en)
|
1994-04-22 |
2000-09-19 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
|
US5683709A
(en)
*
|
1994-05-05 |
1997-11-04 |
Ciba Vision Corporation |
Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
|
TW438601B
(en)
*
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
GB2290964A
(en)
*
|
1994-07-08 |
1996-01-17 |
Arto Olavi Urtti |
Transdermal drug delivery system
|
US5525596A
(en)
*
|
1994-10-21 |
1996-06-11 |
Merck & Co., Inc. |
Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound
|
US5679573A
(en)
*
|
1995-07-27 |
1997-10-21 |
Abbott Laboratories |
Stabilized aqueous steroid immunoassay standards with cyclodextrins
|
FR2738149B1
(fr)
*
|
1995-09-06 |
1997-11-14 |
Chauvin Lab Sa |
Collyre a base d'indometacine pret a l'emploi
|
US5744154A
(en)
*
|
1995-09-06 |
1998-04-28 |
Laboratoire Chauvin S.A. |
Ready-to-use indomethacin-based eye lotion
|
JP2920611B2
(ja)
*
|
1995-12-11 |
1999-07-19 |
株式会社シーエーシー |
皮膚炎の治療外用剤
|
US5773031A
(en)
*
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
ATE298582T1
(de)
|
1996-04-19 |
2005-07-15 |
Alpha Therapeutic Corp |
Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen
|
US5906981A
(en)
*
|
1996-06-04 |
1999-05-25 |
Troy Corporation |
Halopropargyl inclusion complexes
|
JP2000510874A
(ja)
*
|
1997-03-11 |
2000-08-22 |
ヘクサル アーゲー |
バルプロン酸ナトリウム塩の固体、非潮解性処方物
|
DE19713092A1
(de)
*
|
1997-03-27 |
1998-10-01 |
Wacker Chemie Gmbh |
Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
|
US6537537B2
(en)
|
1997-06-12 |
2003-03-25 |
The Procter & Gamble Company |
Water-in-silicone emulsion cosmetic compositions
|
GB9712269D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
GB9712272D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
US6316010B2
(en)
|
1997-06-12 |
2001-11-13 |
The Procter & Gamble Company |
Cosmetic compositions
|
GB9712271D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
AU750207B2
(en)
*
|
1997-06-13 |
2002-07-11 |
Cydex Pharmaceuticals, Inc. |
Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
|
US6699849B1
(en)
*
|
1998-02-23 |
2004-03-02 |
Cyclops, Ehf. |
Cyclodextrin complexes of benzodiazepines
|
JP2003522207A
(ja)
*
|
1998-02-23 |
2003-07-22 |
サイクロプス・イーエイチエフ |
高エネルギーシクロデキストリン複合体
|
US6403605B1
(en)
|
1998-05-29 |
2002-06-11 |
Queen's University At Kingston |
Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
|
NZ330726A
(en)
*
|
1998-06-18 |
2000-10-27 |
Dec Res |
Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
|
WO2000012137A1
(en)
*
|
1998-09-02 |
2000-03-09 |
Allergan Sales, Inc. |
Preserved cyclodextrin-containing compositions
|
US20020198174A1
(en)
*
|
2001-05-07 |
2002-12-26 |
Allergan Sales, Inc. |
Disinfecting and solubilizing steroid compositions
|
GB9822681D0
(en)
*
|
1998-10-16 |
1998-12-09 |
Vitabiotics Ltd |
Method of treatment
|
UA74141C2
(uk)
*
|
1998-12-09 |
2005-11-15 |
Дж.Д. Сірл Енд Ко. |
Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
|
US6290946B1
(en)
*
|
1999-05-13 |
2001-09-18 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as toxin binders and antibacterial agents
|
US6270755B1
(en)
*
|
1999-05-13 |
2001-08-07 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as toxin binders
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
WO2001001955A1
(en)
*
|
1999-07-02 |
2001-01-11 |
Janssen Pharmaceutica N.V. |
Nasal formulation of an antifungal
|
US7069226B1
(en)
|
1999-07-07 |
2006-06-27 |
Synetic, Incorporated |
Prescription data processing system for determining new therapy starts
|
AUPQ633900A0
(en)
*
|
2000-03-20 |
2000-04-15 |
Jurox Pty Ltd |
Anaesthetic composition
|
SI1278549T1
(sl)
*
|
2000-05-02 |
2009-04-30 |
Theravance Inc |
Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik
|
CA2314494A1
(en)
|
2000-05-02 |
2001-11-02 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as species specific antibacterial agents
|
SG98393A1
(en)
|
2000-05-19 |
2003-09-19 |
Inst Materials Research & Eng |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
FR2809311A1
(fr)
*
|
2000-05-23 |
2001-11-30 |
Chauvin Lab Sa |
Solution ophtalmique a base d'acetazolamide destinee au traitement du glaucome
|
US6468989B1
(en)
*
|
2000-07-13 |
2002-10-22 |
Dow Pharmaceutical Sciences |
Gel compositions containing metronidazole
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
GB0027180D0
(en)
|
2000-11-07 |
2000-12-27 |
Unilever Plc |
Cosmetic and personal care compositions
|
ME00293B
(me)
*
|
2000-12-20 |
2011-05-10 |
Bayer Ip Gmbh |
Sastavi estrogen-ciklodekstrin kompleksa
|
EP1216713A1
(en)
*
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
US20030064103A1
(en)
*
|
2001-05-01 |
2003-04-03 |
Lin Shun Y. |
Compositions and methods for treating vulvovaginitis and vaginosis
|
US20060172007A1
(en)
*
|
2001-05-01 |
2006-08-03 |
Nawaz Ahmad |
Compositions and methods for reducing vaginal pH
|
US20030017207A1
(en)
*
|
2001-05-01 |
2003-01-23 |
Lin Shun Y. |
Compositions and methods for treating vulvovaginitis and vaginosis
|
US20040214797A1
(en)
*
|
2001-05-07 |
2004-10-28 |
Allergan, Inc. |
Preserved pharmaceutical compositions comprising cyclodextrins
|
CA2463687A1
(en)
*
|
2001-10-18 |
2003-04-24 |
Decode Genetics Ehf |
Cyclodextrin complexes
|
KR20030041577A
(ko)
*
|
2001-11-20 |
2003-05-27 |
디디에스텍주식회사 |
난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
|
US6881726B2
(en)
*
|
2001-12-24 |
2005-04-19 |
Dow Pharmaceutical Sciences |
Aqueous compositions containing metronidazole
|
DE60112955D1
(de)
*
|
2001-12-28 |
2005-09-29 |
Sandra Cosci |
Zyklodextrin-Komplexe mit Kalium Ion Homeostasis Regulatoren
|
US20090215735A1
(en)
*
|
2002-02-25 |
2009-08-27 |
Alcon, Inc. |
Topical solution formulations containing a corticosteroid and a cyclodextrin
|
DE10211192A1
(de)
*
|
2002-03-14 |
2003-09-25 |
Beiersdorf Ag |
Isoflavanoide gegen Hautalterung und Akne
|
US20060105008A1
(en)
*
|
2002-03-28 |
2006-05-18 |
Nawaz Ahmad |
Compositions and methods for reducing vaginal pH
|
PT1499361E
(pt)
*
|
2002-04-19 |
2012-11-22 |
Novartis Ag |
Novos biomateriais, sua preparação e utilização
|
US6824763B2
(en)
|
2002-05-30 |
2004-11-30 |
Kimberly-Clark Worldwide, Inc. |
Anti-fungal powder having enhanced excipient properties
|
KR101101261B1
(ko)
*
|
2002-07-19 |
2012-01-04 |
인스티튜트 오브 머티어리얼스 리서치 & 엔지니어링 |
생체분해성 삼블럭 공중합체, 이의 합성 방법, 및이로부터 제조된 하이드로겔 및 생체물질
|
CN101319023A
(zh)
*
|
2002-07-22 |
2008-12-10 |
基酶有限公司 |
聚(钾和钠的苯乙烯苯磺酸盐),其制备及其用途
|
AU2003299872A1
(en)
*
|
2002-12-20 |
2004-07-22 |
Board Of Regents, The University Of Texas System |
Vmp-like sequences of pathogenic borrelia species and strains
|
DE10260873A1
(de)
*
|
2002-12-23 |
2004-07-15 |
Beiersdorf Ag |
Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
|
US7993654B2
(en)
*
|
2002-12-23 |
2011-08-09 |
Beiersdorf Ag |
Self-adhesive polymer matrix containing sea algae extract
|
DE10260872B4
(de)
|
2002-12-23 |
2013-09-26 |
Beiersdorf Ag |
Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
EP1709975A1
(en)
*
|
2003-07-10 |
2006-10-11 |
Kyowa Hakko Kogyo Co., Ltd. |
Tablet and process for producing the same
|
US7488739B2
(en)
*
|
2003-07-24 |
2009-02-10 |
Astellas Pharma Inc. |
Quinolone derivative or salt thereof
|
US20050065062A1
(en)
*
|
2003-09-24 |
2005-03-24 |
3M Innovative Properties Company |
Method of formulating a pharmaceutical composition
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
KR20070007075A
(ko)
|
2003-12-31 |
2007-01-12 |
사이덱스 인크 |
술포알킬 에테르 시클로덱스트린 및 코르티코스테로이드를함유한 흡입용 제형
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
BRPI0506983A
(pt)
|
2004-01-20 |
2007-07-03 |
Allergan Inc |
composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
|
US20050234018A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
WO2005104712A2
(en)
|
2004-04-23 |
2005-11-10 |
Cydex, Inc. |
Dpi formulation containing sulfoalkyl ether cyclodextrin
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US20050272700A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Servet Buyuktimkin |
Topical treatment and prevention of human papilloma virus (HPV) infection
|
EP2216026B1
(en)
*
|
2004-07-12 |
2016-04-20 |
Allergan, Inc. |
Ophthalmic compositions and uses for treating ophthalmic conditions
|
WO2006011044A1
(en)
*
|
2004-07-22 |
2006-02-02 |
Pfizer Products Inc. |
Amorphous cyclodextrin compositions
|
AU2005289415A1
(en)
*
|
2004-09-24 |
2006-04-06 |
Rfe Pharma Llc |
Carboxy-amido-triazoles for the localized treatment of ocular diseases
|
MX2007003718A
(es)
*
|
2004-09-27 |
2007-04-23 |
Cargill Inc |
Complejos de inclusion de ciclodextrina y metodos para preparar los mismos.
|
US20060093675A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Mathew Ebmeier |
Intravaginal treatment of vaginal infections with metronidazole compositions
|
US8296162B1
(en)
|
2005-02-01 |
2012-10-23 |
Webmd Llc. |
Systems, devices, and methods for providing healthcare information
|
RU2008101417A
(ru)
*
|
2005-06-13 |
2009-07-20 |
Карджилл Инкорпорейтед (Us) |
Комплексы включения циклодекстрина и способы их получения
|
MX2007015862A
(es)
*
|
2005-06-13 |
2008-02-22 |
Cargill Inc |
Complejos de inclusion de ciclodextrina y metodos para preparar los mismos.
|
US20080003296A1
(en)
*
|
2005-07-11 |
2008-01-03 |
Ketner Rodney J |
Amorphous Cyclodextrin Compositions
|
US7893040B2
(en)
|
2005-07-22 |
2011-02-22 |
Oculis Ehf |
Cyclodextrin nanotechnology for ophthalmic drug delivery
|
WO2007047253A2
(en)
*
|
2005-10-11 |
2007-04-26 |
Eastman Chemical Company |
Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
PL2581078T3
(pl)
|
2005-10-26 |
2015-07-31 |
Cydex Pharmaceuticals Inc |
Kompozycje eteru sulfoalkilowego cyklodekstryny i sposoby ich wytwarzania
|
US20070238789A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Chin-Ming Chang |
Prednisolone acetate compositions
|
EP2027136A4
(en)
*
|
2006-06-13 |
2011-08-03 |
Cargill Inc |
Large part cyclicxtrin inclusion complexes and method for their preparation
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
US8115005B2
(en)
|
2006-08-04 |
2012-02-14 |
Decode Genetics Ehf. |
Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
|
WO2008019284A1
(en)
*
|
2006-08-04 |
2008-02-14 |
Decode Genetics Ehf |
Phenoxymethylalkyne inhibitors of lta4h for treating inflammation
|
US20080097335A1
(en)
*
|
2006-08-04 |
2008-04-24 |
Allergan, Inc. |
Ocular implant delivery assemblies
|
US7989480B2
(en)
*
|
2006-08-04 |
2011-08-02 |
Decode Genetics Ehf |
Aryl amino acid derivatives as inhibitors for treating inflammation
|
EP2049083A2
(en)
*
|
2006-12-27 |
2009-04-22 |
Cargill, Incorporated |
Stabilisation by preparing cyclodextrin inclusion complexes
|
US8380530B2
(en)
|
2007-02-02 |
2013-02-19 |
Webmd Llc. |
Personalized health records with associative relationships
|
WO2008106721A1
(en)
*
|
2007-03-02 |
2008-09-12 |
University Of Wollongong |
Compositions and methods for delivery of anti-cancer agents
|
EP2152078B8
(en)
|
2007-04-27 |
2021-03-17 |
CyDex Pharmaceuticals, Inc. |
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
US20080283693A1
(en)
*
|
2007-05-15 |
2008-11-20 |
Evans Michael J F |
Propulsion apparatus and system
|
EP2550967A1
(en)
*
|
2007-07-11 |
2013-01-30 |
Fertin Pharma A/S |
Compressed chewing gum tablet comprising taste-masking agent
|
DK2178521T3
(da)
*
|
2007-07-11 |
2014-04-28 |
Fertin Pharma As |
Stabilt medicinsk tyggegummi omfattende cyclodextrin-inklusionskompleks
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
WO2010047831A1
(en)
*
|
2008-10-23 |
2010-04-29 |
Nycomed Us Inc. |
Stable metronidazole gel formulations
|
WO2010053487A1
(en)
|
2008-11-07 |
2010-05-14 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
US8545554B2
(en)
*
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
US8236782B2
(en)
|
2009-05-13 |
2012-08-07 |
Cydex Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
MX357677B
(es)
|
2009-05-29 |
2018-07-19 |
Cydex Pharmaceuticals Inc |
Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de fabricación y uso de las mismas.
|
US8658129B2
(en)
*
|
2009-06-04 |
2014-02-25 |
General Electric Company |
Agents and methods for the imaging of myelin basic protein
|
US9968564B2
(en)
|
2009-06-05 |
2018-05-15 |
Intercontinental Great Brands Llc |
Delivery of functional compounds
|
US20100310726A1
(en)
|
2009-06-05 |
2010-12-09 |
Kraft Foods Global Brands Llc |
Novel Preparation of an Enteric Release System
|
US8859003B2
(en)
|
2009-06-05 |
2014-10-14 |
Intercontinental Great Brands Llc |
Preparation of an enteric release system
|
HUP0900698A2
(en)
|
2009-11-06 |
2011-06-28 |
Richter Gedeon Nyrt |
Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
|
US10328152B2
(en)
|
2011-06-16 |
2019-06-25 |
Nayan Patel |
Method for stabilization and delivery of therapeutic molecules
|
DK2814849T3
(da)
|
2012-02-15 |
2020-03-09 |
Cydex Pharmaceuticals Inc |
Fremgangsmåde til fremstilling af cyclodextrin-derivater
|
AU2013226073B2
(en)
|
2012-02-28 |
2016-05-05 |
Cydex Pharmaceuticals, Inc. |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
CA2888822C
(en)
|
2012-10-22 |
2021-01-26 |
Cydex Pharmaceuticals, Inc. |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
JP2015534990A
(ja)
|
2012-10-22 |
2015-12-07 |
イージェニックス インコーポレイテッド |
誤制御されたeIF4Eに関連する疾患又は障害を治療又は予防するための組成物及び方法
|
US8859005B2
(en)
|
2012-12-03 |
2014-10-14 |
Intercontinental Great Brands Llc |
Enteric delivery of functional ingredients suitable for hot comestible applications
|
CA2915405A1
(en)
|
2013-06-13 |
2014-12-18 |
Veroscience Llc |
Compositions and methods for treating metabolic disorders
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
JP6914188B2
(ja)
|
2014-08-22 |
2021-08-04 |
サイデックス・ファーマシューティカルズ・インコーポレイテッド |
分画アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法
|
CA2936748C
(en)
|
2014-10-31 |
2017-08-08 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
DE202016100357U1
(de)
*
|
2016-01-27 |
2016-03-09 |
Peter Sommer |
Pharmazeutische Zubereitung und deren Verwendung bei viralen, entzündlichen Erkrankungen der oberen Atemwege
|
US10722498B2
(en)
|
2017-01-27 |
2020-07-28 |
Shilpa Medicare Limited |
Acetazolamide ophthalmic solution
|
US20200246263A1
(en)
*
|
2017-08-29 |
2020-08-06 |
Fresenius Kabi Oncology Limited |
Stable liquid compositions of pemetrexed
|
AU2019367327A1
(en)
*
|
2018-10-24 |
2021-05-20 |
Adama Makhteshim Ltd. |
Use of cyclodextrins as agrochemical delivery system
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2021250482A1
(en)
|
2020-06-11 |
2021-12-16 |
Sentiss Pharma Private Limited |
Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent
|